Evidence map›Paper›PMID 32963697›Full record

ArticleOxidative medicine and cellular longevity2020

Functional Redox Proteomics Reveal That

Yu-Chiang Hung, Pei-Wen Wang, Tung-Yi Lin, Pei-Ming Yang, Jyh-Sheng You, Tai-Long Pan

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Potential chemoprotective effects of active ingredients inFrontiers in cardiovascular medicine · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Yu-Chiang HungDepartment of Chinese Medicine, College of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung, Taiwan.
Pei-Wen WangDepartment of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-0937-3108
Tung-Yi LinDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.
Pei-Ming YangTMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
Jyh-Sheng YouSchool of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan.
Tai-Long PanSchool of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan.ORCID https://orcid.org/0000-0002-0187-8689
Chang Gung University · TWChang Gung Memorial Hospital · TWChang Gung University of Science and Technology · TWChina Medical University · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anticancer agent adriamycin (ADR) has long been recognized to induce a dose-limiting cardiotoxicity, while

Indexed as

ApoptosisProteomicsAnimalsAntioxidantsBreast NeoplasmsCardiomyopathiesCardiotonic AgentsCaspase 3Cell DeathCell SurvivalDoxorubicinHumansMaleMCF-7 CellsModels, BiologicalOxidation-ReductionAntioxidantsCardiotonic AgentsCaspase 3DoxorubicinPlant ExtractsReactive Oxygen SpeciesWater

Identifiers

PMID32963697
PMCPMC7501560
OpenAlexW3083924715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.